Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $24.5600 (-0.69%) ($24.4300 - $25.6000) on Mon. Jul. 18, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.03% (three month average) | RSI | 59 | Latest Price | $24.5600(-0.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.6% a day on average for past five trading days. | Weekly Trend | EDIT advances 0.4% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(60%) IBB(59%) XBI(58%) IWO(55%) ARKK(54%) | Factors Impacting EDIT price | EDIT will decline at least -2.015% in a week (0% probabilities). VIXM(-14%) TLT(-6%) SHY(-6%) IPO(-4%) GDXJ(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.015% (StdDev 4.03%) | Hourly BBV | 0 () | Intraday Trend | -0.7% | | | |
|
1 - 5 Day Possible Target | $14.56(-40.72%) | Resistance Level | $25.71 | 5 Day Moving Average | $25.01(-1.8%) | 10 Day Moving Average | $25.18(-2.46%) | 20 Day Moving Average | $25.71(-4.47%) | To recent high | -39.6% | To recent low | 2.9% | Market Cap | $1.525b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |